Suprax may be administered in the presence of impaired renal function.
Normal dose and schedule may be employed in patients with creatinine
clearances of 60 mL/min or greater. Patients whose clearance is between
21 and 60 mL/min or patients who are on renal hemodialysis may be given
75% of the standard dosage at the standard dosing interval (i.e., 300 mg
daily). Patients whose clearance is < 20 mL/min, or patients who are on
continuous ambulatory peritoneal dialysis may be given half the standard
dosage at the standard dosing interval (i.e., 200 mg daily). Neither
hemodialysis nor peritoneal dialysis remove significant amounts of drug
from the body.
National Institutes of Health, U.S. National Library of Medicine,
DailyMed Database. Provides access to the latest drug monographs submitted to the
Food and Drug Administration (FDA). Please review the latest applicable package insert for
additional information and possible updates. A local search
option of this data can be found here.
The authors make no claims of the accuracy of the information contained herein; and these suggested doses are not a substitute for clinical
judgment. Neither GlobalRPh Inc. nor any other party involved in the
preparation of this program shall be liable for any special, consequential, or exemplary damages resulting in whole or part from any user's use of or reliance upon this material.PLEASE READ THE DISCLAIMER
BEFORE ACCESSING OR USING THIS SITE. BY ACCESSING OR USING THIS SITE, YOU
AGREE TO BE BOUND BY THE TERMS AND CONDITIONS SET FORTH IN THE DISCLAIMER. Read